Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shannon Carter

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of the American College of Cardiology|July 24, 2012
Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillationMarylyn D Ritchie, Shane Rowan, Gayle Kucera, et al.
Journal of the American College of Cardiology|June 26, 2012
Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillationBabar Parvez, Joseph Vaglio, Shane Rowan, et al.
Circulation. Cardiovascular Genetics|November 22, 2011
A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointesStefan Kääb, Dana C Crawford, Moritz F Sinner, et al.
Nature Genetics|July 15, 2009
A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic strokeDaniel F Gudbjartsson, Hilma Holm, Solveig Gretarsdottir, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of the American College of Cardiology|July 24, 2012
Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillationMarylyn D Ritchie, Shane Rowan, Gayle Kucera, et al.
Journal of the American College of Cardiology|June 26, 2012
Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillationBabar Parvez, Joseph Vaglio, Shane Rowan, et al.
Circulation. Cardiovascular Genetics|November 22, 2011
A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointesStefan Kääb, Dana C Crawford, Moritz F Sinner, et al.
Nature Genetics|July 15, 2009
A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic strokeDaniel F Gudbjartsson, Hilma Holm, Solveig Gretarsdottir, et al.
Pageof 2